Market Research Report
Single use Bioreactors Market Size, Share & Trends Analysis By Product, By Type, By Type of Cell, By Molecule Type, By Application, By End-Users, By, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
|Single use Bioreactors Market Size, Share & Trends Analysis By Product, By Type, By Type of Cell, By Molecule Type, By Application, By End-Users, By, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030|
Published: May 12, 2022
SPER Market Research Pvt. Ltd.
Content info: 236 Pages
Delivery time: 1-2 business days
The global Single-use Bioreactors Market is projected to be worth USD 17.28 billion by 2030.
According to SPER Market Research, the Single-use Bioreactors Market is estimated to reach USD 17.28 billion by 2030 with a CAGR of 19.8%.
Escalating Biopharmaceutical research & development, growing technological advancements in SUBs, acceptance of SUBs amongst start-ups, and small companies, abridged automation difficulty, simplicity in the farming of marine organisms, condensed energy and water consumption, and the increasing biologics market; are the key factors for the expansion of the market.
The outbreak of COVID-19, provide positive growth in this market, and big pharmaceutical and biopharmaceutical companies increased their investment in research & development, and manufacturing of vaccines and test kits in large numbers.
Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East, Africa.
Companies Covered: ABEC, Inc., Able Corporation & Biott Corporation, Avantor, bbi-biotech GmbH, Cellexus, Cell culture company, Celltainer Biotech, CESCO Bioengineering Co. Ltd., Corning, Danaher Corporation, Distek, Inc., Entegris, Eppendorf AG, G&G Technologies, Getinge AB, Kuhner AG, Meissner Filtration Products, Inc., Merck KGaA, OmniBRx Biotechnologies, PBS Biotech, Inc., Pierre Guerin, Sartorius Stedim Biotech S.A., Satake Chemical Equipment Mfg., Ltd., Solida Biotech GmbH, Stobbe Pharma GmbH, Thermo Fisher Scientific.
Growing geriatric population, growing acceptance of SUBs among small companies and start-ups, abridged automation difficulty, simplicity in the farming of marine organisms, reduced energy and water consumption, rising biologics market, technological advancements in SUBs, and growing biopharmaceutical research & development; are the key factors for the expansion of the market.
Improvement in single-use sensors, standardization of single-use design, Regulatory concerns related to SUBs, and Issues related to leachable and extractable; are the challenges to this market.
The growing demands for pharmaceutical & biopharmaceutical research & development in the emerging economies offer vast opportunities.
Based on the product, Single-use Bioreactors Market is segmented as; Single-use Bioreactor Systems (Up to 10L, 11-100L, 101-500L, 501-1500L, Above 1500L), Single-use Media Bags (2D Bags, 3D Bags, Other Bags), Single-use Filtration Assemblies, Other Products (Single-use vessels, tubing and connectors, samplers, and probes/sensor, and others).
Based on the Type, Single-use Bioreactors Market is segmented as; Bubble-column SUBs, Other SUBs (Hybrid bioreactors and SUBs with vertically perforated discs), Stirred-tank SUBs, and Wave-induced SUBs.
Based on the Type of Cell, Single-use Bioreactors Market is segmented as; Bacterial Cells, Mammalian Cells, Other Cells (Insect and plant cells), and Yeast Cells.
Based on the type of molecule, Single-use Bioreactors Market is segmented as; Gene-modified cells, Monoclonal Antibodies, and Other Molecules (Recombinant proteins including growth factors & interferon, antisense, RNA interference, and others), Stem Cells, and Vaccines.
Based on the Type of Application, Single-use Bioreactors Market is segmented as; Bio-production, Process Development, Research, and Development
Based on the End-Users, Single-use Bioreactors Market is segmented as; Academic & Research Institutes, Biopharmaceutical & Pharmaceutical companies, Contract Research Organizations, and contract manufacturing organizations (CROs & CMOs).
North America owns the principal share of this market; this is due to the concentration of established biopharmaceutical industries, and key players functioning in the single-use bioreactors market.